This document provides a summary of a pharma key account management report from 2011-2012. The report examines the successful implementation of key account management (KAM) in order to increase stakeholder satisfaction, market share, and profitability. It discusses organizational changes needed to transition to a KAM model, challenges in measurement and incentivization, and examples of delivering value to key accounts. The summary provides high-level insights into the challenges and opportunities of implementing KAM strategies.
“Marketing 2.0” in the pharmaceutical industry is no longer about just saying that our product is different and hoping customers will see it that way. It’s very much about making it so and then about finding our way to engage customers in a “conversation” that helps create the value rather than just promoting it through armies of medical representatives. We need to develop new, end-to-end processes that shape our relationships with physicians, payers, patients and care-givers.
Pharmaceutical Marketing - Whats in store for patients?brandsynapse
This document discusses trends in pharmaceutical marketing and advertising spending from 1996 to 2010. Key points include:
- U.S. pharmaceutical ad spending peaked at $5.4 billion in 2006 but has declined each year since to $4.3 billion in 2010 due to fewer blockbuster drugs, a smaller new drug pipeline, and cost cutting.
- The top spender in 2010 was Pfizer at $967.5 million, though its drug Lipitor will go off patent in 2011. Other top drugs like Plavix and Singulair will also lose patent protection.
- As mainstream breakthrough drugs become fewer, pharmaceutical marketers will need to create more value for newer drugs with smaller benefits and target niche patient
Strategies to Enhance Pharmacy Benefit ManagementTransparentRx
This document provides strategies for self-insured employers to better manage pharmacy benefit costs and performance. It recommends marshaling in-house expertise to better understand how PBMs generate profits through various pricing strategies. It also suggests replacing traditional RFP processes with reverse auctions to drive more competitive pricing from PBMs, particularly for specialty drugs. Overall, the document aims to educate employers on optimizing PBM contracts and strategies to control rising prescription drug costs.
The document summarizes mentorship and training programs offered by The Mentor to pharmacy students and professionals. Over 1 million students will graduate in the next two years but only 100 will have jobs, so students must develop skills to make themselves employable. The Mentor offers programs to sharpen knowledge, skills, and attitudes in areas like communication, leadership, sales and more. It has partnerships with major pharmaceutical companies and provides career assistance and placement opportunities. Students can contact The Mentor at the provided address and phone numbers for more details.
Pharma Sales Crediting: Incentives for Accurate & Compliant ProcessesCognizant
The document discusses the complex process of incentivizing pharmaceutical sales representatives. It notes that designing sales incentive programs involves establishing quotas, measuring performance against quotas, and ensuring accurate sales data collection and mapping to territories while complying with regulations. An effective sales crediting process requires mapping prescription data to territories, applying business rules to remain compliant, and conducting quality checks to avoid errors and lawsuits. Key challenges include mapping scripts to reps, handling roster changes, and clearly defining rules to demonstrate fair compensation and avoid litigation.
Launch readiness 3 keys to success for sales leadersDario Priolo
The document discusses 3 keys for sales leaders to successfully launch new products: 1) Align product messaging with customer needs by focusing on how the product solves problems rather than just product attributes. Develop "solution messaging cards" to guide discussions. 2) Align sales competencies with new customer expectations around account management, consultative dialogues, and clinical selling skills. 3) Assess sales teams' competency levels and create learning plans to prepare them for the critical first 6 months of a product launch. Proper preparation across these three areas can help sales teams maximize their impact within the key launch window.
This document provides a summary of a pharma key account management report from 2011-2012. The report examines the successful implementation of key account management (KAM) in order to increase stakeholder satisfaction, market share, and profitability. It discusses organizational changes needed to transition to a KAM model, challenges in measurement and incentivization, and examples of delivering value to key accounts. The summary provides high-level insights into the challenges and opportunities of implementing KAM strategies.
“Marketing 2.0” in the pharmaceutical industry is no longer about just saying that our product is different and hoping customers will see it that way. It’s very much about making it so and then about finding our way to engage customers in a “conversation” that helps create the value rather than just promoting it through armies of medical representatives. We need to develop new, end-to-end processes that shape our relationships with physicians, payers, patients and care-givers.
Pharmaceutical Marketing - Whats in store for patients?brandsynapse
This document discusses trends in pharmaceutical marketing and advertising spending from 1996 to 2010. Key points include:
- U.S. pharmaceutical ad spending peaked at $5.4 billion in 2006 but has declined each year since to $4.3 billion in 2010 due to fewer blockbuster drugs, a smaller new drug pipeline, and cost cutting.
- The top spender in 2010 was Pfizer at $967.5 million, though its drug Lipitor will go off patent in 2011. Other top drugs like Plavix and Singulair will also lose patent protection.
- As mainstream breakthrough drugs become fewer, pharmaceutical marketers will need to create more value for newer drugs with smaller benefits and target niche patient
Strategies to Enhance Pharmacy Benefit ManagementTransparentRx
This document provides strategies for self-insured employers to better manage pharmacy benefit costs and performance. It recommends marshaling in-house expertise to better understand how PBMs generate profits through various pricing strategies. It also suggests replacing traditional RFP processes with reverse auctions to drive more competitive pricing from PBMs, particularly for specialty drugs. Overall, the document aims to educate employers on optimizing PBM contracts and strategies to control rising prescription drug costs.
The document summarizes mentorship and training programs offered by The Mentor to pharmacy students and professionals. Over 1 million students will graduate in the next two years but only 100 will have jobs, so students must develop skills to make themselves employable. The Mentor offers programs to sharpen knowledge, skills, and attitudes in areas like communication, leadership, sales and more. It has partnerships with major pharmaceutical companies and provides career assistance and placement opportunities. Students can contact The Mentor at the provided address and phone numbers for more details.
Pharma Sales Crediting: Incentives for Accurate & Compliant ProcessesCognizant
The document discusses the complex process of incentivizing pharmaceutical sales representatives. It notes that designing sales incentive programs involves establishing quotas, measuring performance against quotas, and ensuring accurate sales data collection and mapping to territories while complying with regulations. An effective sales crediting process requires mapping prescription data to territories, applying business rules to remain compliant, and conducting quality checks to avoid errors and lawsuits. Key challenges include mapping scripts to reps, handling roster changes, and clearly defining rules to demonstrate fair compensation and avoid litigation.
Launch readiness 3 keys to success for sales leadersDario Priolo
The document discusses 3 keys for sales leaders to successfully launch new products: 1) Align product messaging with customer needs by focusing on how the product solves problems rather than just product attributes. Develop "solution messaging cards" to guide discussions. 2) Align sales competencies with new customer expectations around account management, consultative dialogues, and clinical selling skills. 3) Assess sales teams' competency levels and create learning plans to prepare them for the critical first 6 months of a product launch. Proper preparation across these three areas can help sales teams maximize their impact within the key launch window.
This document discusses communication strategies for pharmaceutical marketing. It notes that pharmaceutical companies have traditionally relied on personal selling to doctors due to legal restrictions on other forms of promotion. However, new communication methods like websites, emails, and medical journal ads are becoming more common. Going forward, web-based communication and digital marketing are expected to play a larger role in pharmaceutical promotion. Effective communication requires adopting the right blend of personal and non-personal approaches tailored to each product and customer.
The document discusses marketing management in the pharmaceutical industry. It provides insights into the roles and responsibilities of marketers and brand managers in the industry. It discusses key aspects of marketing management including market research, forecasting, business modeling, communication strategies, training sales teams, monitoring results, and working with third party agencies. It also provides data on the Pakistani pharmaceutical market size and growth of top companies. Global prevalence data and projections for hypertension are presented to illustrate how marketers select markets to serve.
Description of the "KAM Expert Wheel" which is a method to structure the activities of Key Account Managers and help them cope with the complexity of their task
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
This document discusses considerations for pharmaceutical companies deciding whether to take a brand over-the-counter (OTC). Key factors that may favor going OTC include growing consumer awareness, changing patient behaviors, and high costs of sales teams. However, other factors must also be considered, such as the target audience's view of the indication, financial resources required for mass media advertising, developing sales team skills for engaging consumers and chemists, distribution challenges, and licensing requirements for non-chemist outlets. The document examines these strategic and operational issues to help brand managers evaluate if going OTC makes sense for their brand.
Survey report pharmaceutical marketing ethical and responsible conductbrandsynapse
The survey found that over 50% of respondents believe that guidelines from the Medical Council of India and Department of Pharmaceuticals on interactions between pharmaceutical companies and healthcare professionals will not be effective in ensuring ethical marketing of drugs in India due to a lack of legislative support and potential for manipulation. Additionally, around 72% felt that the Medical Council was not strongly enforcing its own ethics guidelines. Only 36% believed the Medical Council's guidelines would impact drug sales.
Pharmaceutical marketing by vikram mathariyaAshish Agrawal
This document provides an overview of pharmaceutical marketing. It discusses key concepts like defining a market, the importance of marketing and market research, and how pharmaceutical marketing is similar to but also differs from general marketing due to physicians making drug selection decisions. The document also outlines several core functions of marketing like buying, selling, transportation, storage, financing, and risk taking. It provides details on how these functions apply to pharmaceutical marketing and distribution.
Branding is increasingly important in the pharmaceutical industry. Doctors act as brand ambassadors while companies rely on R&D, patents, and sales forces. Branding differentiates products, creates product awareness, and builds emotional connections with customers. In the competitive environment, branding can provide a new advantage. Companies spend more on brand building and brand acquisitions show branding's importance. Branded generics, direct-to-consumer advertising, and ensuring brand relevance over time are important strategies. Strong brands benefit from increased loyalty and help prolong a product's commercial life.
Prescription for Growth: Embrace a NicheRolandJacobs1
Roland Jacobs is CEO of marketing strategy firm AspireUp
Tim Calkins is a clinical professor of marketing, including biomedical marketing, at the Kellogg School of Management at Northwestern
Быть или не быть специализированному аптечному филдфорсу?Infor-media
This document discusses the potential benefits and challenges of establishing a specialized retail sales team to promote pharmaceutical products directly to pharmacies. Some key points:
- A retail sales team could increase sales by up to 33% by reducing the rate of generic substitution from 40% to 20% through improved availability, recommendations, and avoidance of switching at the point of sale.
- Managing interactions between medical and retail teams will be important, and changes to promotional strategies for pharmacies may cause issues. Careful planning of structure, roles, training, and incentives will be needed.
- A retail team could improve coverage, targeting, and segmentation of pharmacies. This has the potential to increase customer satisfaction and drive greater sales while optim
1) The document discusses pharmaceutical product marketing and sales. It describes the pharmaceutical company organizational structure and key departments.
2) It explains that in the pharmaceutical industry, doctors act as customers by identifying patient needs and prescribing products, while patients are the consumers who use the products. Selling involves promoting products to doctors rather than directly to patients.
3) The roles of different customers in the pharmaceutical supply chain are discussed, including doctors who prescribe, chemists who dispense prescriptions, and stockists who supply products to chemists. Pharmaceutical marketing professionals work to promote their products to doctors as the indirect customers who influence which treatments patients receive.
The traditional decision journey of patients and doctors is being disrupted by digital technologies. Patients and doctors are increasingly using digital tools to research treatments and connect with peers. This rapid adoption of technology has caught healthcare businesses off guard. For pharmaceutical companies to succeed in this new digital environment, they need to undergo a digital transformation that involves realigning business models, technologies, and processes around customer value. However, the biggest challenge for companies is not adopting new technologies, but changing internal mindsets to think digitally. Companies must establish new digital ecosystems and take a long term innovative approach to digital strategies.
Experienced sales professional with over 15 years in the medical industry seeking a senior sales position. She has a proven track record of exceeding sales goals across multiple therapeutic areas including pain management, gastroenterology, CNS disorders and infectious diseases. She is skilled in relationship building with physicians, consultation, customer service, and leadership.
This document provides an overview of how businesses use market research through various methods like primary and secondary research, qualitative and quantitative research. It discusses different types of primary research sources like questionnaires, focus groups, mystery shoppers, and observations. It also covers secondary research sources like previous market research, trade journals, books, newspapers, and census data. The advantages and disadvantages of each research method are explained. Overall, the document emphasizes that market research is useful for businesses to understand customer needs and adapt their products and strategies accordingly to increase sales and profits.
Method, tools and recommendations to boost Medical Science Liaisons Competence and performance.
Presentation of best practices to manage key opinion leaders
Metafuzz: Building Boring Fuzzers Faster, Using Metadataamiable_indian
Metafuzz is a framework for building fuzzers in Ruby. It includes components like BinStruct for defining protocol data units, generators for creating output streams, an example fuzzer, and a finite state automata (FSA) tool. The framework allows defining protocol structures, generating fuzzed inputs, and modeling stateful protocols with an FSA to automate state transitions.
The document outlines a marketing campaign for Energizer Ultimate Lithium batteries. It proposes pop-up events in London to generate buzz around the brand's features and drive traffic to their website. Key goals are to increase social media followers, attract thousands of visitors to the pop-up spaces, and boost sales by 6% during the holiday period through positive press coverage and consumer engagement. Metrics such as social mentions, website visits, press articles, and sales will evaluate the campaign's success.
E-Business Suite Release 12 Payables Upgrade: Like for Like and Then Someeprentise
Faced with extended support fees and required patches, Oracle E-Business Suite Release 11i users are seeking a quick Release 12 upgrade. Many companies are choosing a “like for like” approach wherein uptake of new functionality is postponed until after the upgrade. However, R12 introduces new functionality for payments, taxes, invoice entry, and supplier management that must be incorporated. eprentise and guest speaker Karen Brownfield from Infosemantics, Inc. address the required new functionality with hints on configuration thus meeting the upgrade objectives.
Website: www.eprentise.com
Twitter: @eprentise
Google+: https://plus.google.com/u/0/+Eprentise/posts
Facebook: https://www.facebook.com/eprentise
El documento describe una comida donde varias personas están desayunando pan y mantequilla. Una persona llamada Horacio come de manera exagerada, mientras otros le piden que coma más despacio. Otras personas discuten sobre Horacio y toman fotos de él comiendo. Finalmente, terminan de comer y bailan.
The document summarizes the European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) preparatory phase project. It discusses how biobanks across Europe have historically been small and heterogeneous, hindering modern genetic research. The BBMRI aims to integrate existing biobanks and resources to create a large pan-European infrastructure following common standards. The preparatory phase involved over 50 institutions from 28 countries to assess resources and technologies and develop plans for a sustainable infrastructure to support research.
This document discusses communication strategies for pharmaceutical marketing. It notes that pharmaceutical companies have traditionally relied on personal selling to doctors due to legal restrictions on other forms of promotion. However, new communication methods like websites, emails, and medical journal ads are becoming more common. Going forward, web-based communication and digital marketing are expected to play a larger role in pharmaceutical promotion. Effective communication requires adopting the right blend of personal and non-personal approaches tailored to each product and customer.
The document discusses marketing management in the pharmaceutical industry. It provides insights into the roles and responsibilities of marketers and brand managers in the industry. It discusses key aspects of marketing management including market research, forecasting, business modeling, communication strategies, training sales teams, monitoring results, and working with third party agencies. It also provides data on the Pakistani pharmaceutical market size and growth of top companies. Global prevalence data and projections for hypertension are presented to illustrate how marketers select markets to serve.
Description of the "KAM Expert Wheel" which is a method to structure the activities of Key Account Managers and help them cope with the complexity of their task
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
This document discusses considerations for pharmaceutical companies deciding whether to take a brand over-the-counter (OTC). Key factors that may favor going OTC include growing consumer awareness, changing patient behaviors, and high costs of sales teams. However, other factors must also be considered, such as the target audience's view of the indication, financial resources required for mass media advertising, developing sales team skills for engaging consumers and chemists, distribution challenges, and licensing requirements for non-chemist outlets. The document examines these strategic and operational issues to help brand managers evaluate if going OTC makes sense for their brand.
Survey report pharmaceutical marketing ethical and responsible conductbrandsynapse
The survey found that over 50% of respondents believe that guidelines from the Medical Council of India and Department of Pharmaceuticals on interactions between pharmaceutical companies and healthcare professionals will not be effective in ensuring ethical marketing of drugs in India due to a lack of legislative support and potential for manipulation. Additionally, around 72% felt that the Medical Council was not strongly enforcing its own ethics guidelines. Only 36% believed the Medical Council's guidelines would impact drug sales.
Pharmaceutical marketing by vikram mathariyaAshish Agrawal
This document provides an overview of pharmaceutical marketing. It discusses key concepts like defining a market, the importance of marketing and market research, and how pharmaceutical marketing is similar to but also differs from general marketing due to physicians making drug selection decisions. The document also outlines several core functions of marketing like buying, selling, transportation, storage, financing, and risk taking. It provides details on how these functions apply to pharmaceutical marketing and distribution.
Branding is increasingly important in the pharmaceutical industry. Doctors act as brand ambassadors while companies rely on R&D, patents, and sales forces. Branding differentiates products, creates product awareness, and builds emotional connections with customers. In the competitive environment, branding can provide a new advantage. Companies spend more on brand building and brand acquisitions show branding's importance. Branded generics, direct-to-consumer advertising, and ensuring brand relevance over time are important strategies. Strong brands benefit from increased loyalty and help prolong a product's commercial life.
Prescription for Growth: Embrace a NicheRolandJacobs1
Roland Jacobs is CEO of marketing strategy firm AspireUp
Tim Calkins is a clinical professor of marketing, including biomedical marketing, at the Kellogg School of Management at Northwestern
Быть или не быть специализированному аптечному филдфорсу?Infor-media
This document discusses the potential benefits and challenges of establishing a specialized retail sales team to promote pharmaceutical products directly to pharmacies. Some key points:
- A retail sales team could increase sales by up to 33% by reducing the rate of generic substitution from 40% to 20% through improved availability, recommendations, and avoidance of switching at the point of sale.
- Managing interactions between medical and retail teams will be important, and changes to promotional strategies for pharmacies may cause issues. Careful planning of structure, roles, training, and incentives will be needed.
- A retail team could improve coverage, targeting, and segmentation of pharmacies. This has the potential to increase customer satisfaction and drive greater sales while optim
1) The document discusses pharmaceutical product marketing and sales. It describes the pharmaceutical company organizational structure and key departments.
2) It explains that in the pharmaceutical industry, doctors act as customers by identifying patient needs and prescribing products, while patients are the consumers who use the products. Selling involves promoting products to doctors rather than directly to patients.
3) The roles of different customers in the pharmaceutical supply chain are discussed, including doctors who prescribe, chemists who dispense prescriptions, and stockists who supply products to chemists. Pharmaceutical marketing professionals work to promote their products to doctors as the indirect customers who influence which treatments patients receive.
The traditional decision journey of patients and doctors is being disrupted by digital technologies. Patients and doctors are increasingly using digital tools to research treatments and connect with peers. This rapid adoption of technology has caught healthcare businesses off guard. For pharmaceutical companies to succeed in this new digital environment, they need to undergo a digital transformation that involves realigning business models, technologies, and processes around customer value. However, the biggest challenge for companies is not adopting new technologies, but changing internal mindsets to think digitally. Companies must establish new digital ecosystems and take a long term innovative approach to digital strategies.
Experienced sales professional with over 15 years in the medical industry seeking a senior sales position. She has a proven track record of exceeding sales goals across multiple therapeutic areas including pain management, gastroenterology, CNS disorders and infectious diseases. She is skilled in relationship building with physicians, consultation, customer service, and leadership.
This document provides an overview of how businesses use market research through various methods like primary and secondary research, qualitative and quantitative research. It discusses different types of primary research sources like questionnaires, focus groups, mystery shoppers, and observations. It also covers secondary research sources like previous market research, trade journals, books, newspapers, and census data. The advantages and disadvantages of each research method are explained. Overall, the document emphasizes that market research is useful for businesses to understand customer needs and adapt their products and strategies accordingly to increase sales and profits.
Method, tools and recommendations to boost Medical Science Liaisons Competence and performance.
Presentation of best practices to manage key opinion leaders
Metafuzz: Building Boring Fuzzers Faster, Using Metadataamiable_indian
Metafuzz is a framework for building fuzzers in Ruby. It includes components like BinStruct for defining protocol data units, generators for creating output streams, an example fuzzer, and a finite state automata (FSA) tool. The framework allows defining protocol structures, generating fuzzed inputs, and modeling stateful protocols with an FSA to automate state transitions.
The document outlines a marketing campaign for Energizer Ultimate Lithium batteries. It proposes pop-up events in London to generate buzz around the brand's features and drive traffic to their website. Key goals are to increase social media followers, attract thousands of visitors to the pop-up spaces, and boost sales by 6% during the holiday period through positive press coverage and consumer engagement. Metrics such as social mentions, website visits, press articles, and sales will evaluate the campaign's success.
E-Business Suite Release 12 Payables Upgrade: Like for Like and Then Someeprentise
Faced with extended support fees and required patches, Oracle E-Business Suite Release 11i users are seeking a quick Release 12 upgrade. Many companies are choosing a “like for like” approach wherein uptake of new functionality is postponed until after the upgrade. However, R12 introduces new functionality for payments, taxes, invoice entry, and supplier management that must be incorporated. eprentise and guest speaker Karen Brownfield from Infosemantics, Inc. address the required new functionality with hints on configuration thus meeting the upgrade objectives.
Website: www.eprentise.com
Twitter: @eprentise
Google+: https://plus.google.com/u/0/+Eprentise/posts
Facebook: https://www.facebook.com/eprentise
El documento describe una comida donde varias personas están desayunando pan y mantequilla. Una persona llamada Horacio come de manera exagerada, mientras otros le piden que coma más despacio. Otras personas discuten sobre Horacio y toman fotos de él comiendo. Finalmente, terminan de comer y bailan.
The document summarizes the European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) preparatory phase project. It discusses how biobanks across Europe have historically been small and heterogeneous, hindering modern genetic research. The BBMRI aims to integrate existing biobanks and resources to create a large pan-European infrastructure following common standards. The preparatory phase involved over 50 institutions from 28 countries to assess resources and technologies and develop plans for a sustainable infrastructure to support research.
Este documento discute la seguridad en los sistemas mainframe de IBM. Explica que los mainframes son sistemas complejos que ejecutan aplicaciones complejas, por lo que las auditorías de seguridad a menudo se enfocan en aspectos individuales en lugar de una visión integral. También describe brevemente la evolución de los servicios de seguridad en mainframes, la situación de la seguridad en z/OS en 2009, y cómo los directores de sistemas generalmente perciben la seguridad de los mainframes como muy alta a pesar de los desafíos
Este documento describe diferentes metodologías ágiles para el desarrollo de software como la elaboración de prototipos, RAD y programación extrema. Explica los cuatro tipos principales de prototipos, las fases del desarrollo rápido de aplicaciones y los valores, principios y prácticas esenciales de la programación extrema como la comunicación, retroalimentación y valentía. También discute las ventajas y desventajas de estas metodologías ágiles y cómo pueden usarse para mejorar la recopilación de requisitos y ac
La empresa FUNBIKETOUR ofrece el alquiler de bicicletas y visitas guiadas en bicicleta por la ciudad de Sevilla. Ofrece visitas de 2-4 horas a diferentes zonas de Sevilla, como el casco histórico y la Cartuja, por precios de 20-28 euros por persona. La empresa utiliza las redes sociales como Facebook, Twitter y un blog para dar a conocer sus servicios, interactuar con clientes, y medir el impacto de sus promociones.
This document provides an overview of quality in manufacturing and service. It discusses the history of quality, from craft guilds ensuring training to modern quality assurance pioneers developing tools like control charts. Key events that increased U.S. focus on quality include losses to Japanese competitors and the 1987 Malcolm Baldrige Award establishing. The document defines quality as fitness for use and conforming to specifications. It describes quality assurance functions and discusses quality's importance in both manufacturing and service organizations.
This document analyzes payment diary survey data from seven countries to compare consumer cash usage. The surveys were conducted between 2009-2012 in Australia, Austria, Canada, France, Germany, the Netherlands, and the United States. The analysis finds:
1) Cash accounts for 46-82% of payment transactions across countries but its value share varies significantly, from over 50% in Austria and Germany to about 25% in Canada, France, and the US.
2) Non-cash payment instruments used vary by country, with credit cards more common in Australia, Canada, and US, while debit cards are more widely used overall, particularly in the Netherlands.
3) An econometric analysis finds similarities across countries in
DSD-INT 2015- Open source pre and postprocessing workshop- Bert JagersDeltares
The document discusses open source pre- and postprocessing tools for Delft3D including Delft3D-MATLAB tools, OpenEarthTools, RGFGRID, DeltaShell, and Python scripting. It provides overviews of the Delft Dashboard, QuickPlot, Muppet, and GooglePlot tools and how to access, run, and associate files with them.
This document provides a summary of events and activities at Naval Construction Battalion Center (NCBC) Gulfport. It includes:
1) Two Seabees from NMCB 133 received Purple Hearts for injuries sustained in an IED attack in Afghanistan.
2) More than 120 Seabees from NMCB 74 returned from deployment and were welcomed home by family and friends.
3) A list of establishments declared "off limits" to armed forces personnel in the Biloxi, Gulfport, and Pascagoula areas.
4) Information on rights and protections for service members under the Uniformed Services Employment and Reemployment Rights Act.
5) Brief summaries of other
The aim of this study is to estimate the impact of the removal of NTBs in trade between the EU and its selected CIS partners: Russia, Ukraine, Georgia, Armenia and Azerbaijan (CIS5). The report includes a discussion of methodologies of measurement of non-tariff barriers and the impact of their removal, including a review of previous studies focusing on CEE and CIS regions. Further, we employ a computable general equilibrium model encompassing the following three pillars of trade facilitation: legislative and regulatory approximation, reform of customs rules and procedures and liberalization of the access of foreign providers of services. We conclude that a reduction of NTBs and improved access to the EU market would bring significant benefits to the CIS5 countries in terms of welfare gains, GDP growth, increases in real wages and expansion of international trade. The possible welfare implications of deep integration with the EU range from 5.8% of GDP in Ukraine to sizeable expected gains in Armenia (3.1%), Russia (2.8%), Azerbaijan (1.8%) and Georgia (1.7%).
Authored by: Maryla Maliszewska, Irina Orlova, Svitlana Taran
Published in 2009
La guía presenta la primera edición de la Feria de la Industria del Tabaco en Barcelona. Explica que la feria nace del esfuerzo de un equipo humano dedicado a apoyar al sector tabaquero y luchar contra las leyes antitabaco. A lo largo de la feria, los asistentes podrán disfrutar de novedades sobre tabaco, catas de habanos, y conferencias de expertos.
This document provides an overview and summary of a Level 1 Amateur Radio Emergency Communications Course. The course aims to provide baseline knowledge and skills for volunteers assisting with emergency communications. It covers topics like communication emergencies, disaster scenarios in the Pacific Northwest, and the roles and responsibilities of amateur radio operators in emergency situations.
The document is a product catalogue from EMS Physio introducing new and updated products for 2016. Key details include:
- A new 4th generation Megapulse 260 shortwave device with enhanced features including a new operating system and ergonomic design.
- An interactive website providing ongoing communication with customers.
- The product range continues to evolve with innovations in ultrasound, electrotherapy, treatment couches, and other rehabilitation equipment.
Running a successful pharma franchise for neuropsychiatry medicines can be a challenging yet rewarding experience. With the right tips and tricks, you can maximize your profits and ensure that your business is a success. See more information in this infographic.
When Will Indian Pharma Get its Act Together? Anup Soans
Inside this Issue
1. Indian Medical Advisors Summit by Dr. Amit Dang
Photo essay and briefing.
2. Digital Pharma by Chandan Kumar
Digital is changing the fundamentals of the marketplace. Here’s how pharma can keep pace.
3. Selling Across Cultures by Anup Soans and Joshua Soans
Chapter extract from the new book The Art of Modern Sales Management by Renie Mcclay.
4. What You Measure is What Gets Done by Hanno Wolfram
Performance metrics are often a trade-off between ease and value. Is “calls-per-day” a meaningless metric that needs immediate replacement?
5. Book Review: Unlealthy Practices by Anup Soans
Review of the new work of fiction by Dr. Sumit Ghoshal.
Sales Force Effectiveness is Dead ... or is it?
Five opportunities for pharma to get ‘back to basics’ and immediately lift sales performance.
Blackdot are a full service benchmarking, consulting, training & advisory firm exclusively focused on lifting sales force effectiveness & efficiency. Blackdot exist to assist their clients to achieve more predictable, repeatable, and sustainable sales performance.
What makes them unique is their total fixation on the use of data-driven, evidence-based techniques to understand what does (and does not) drive sales performance.
By viewing the ‘sales engine’ holistically, as an ecosystem of component parts that work interdependently to impact sales results, Blackdot are able to identify the root cause of what’s inhibiting and enabling your current performance, including quantifying the payoff in actually getting it right.
Armed with this knowledge, Blackdot stand alongside their clients who engage them to define, implement and embed change programs that bridge the gap between ‘hoping’ and ‘knowing’ they’ll deliver top and bottom line performance improvement.
How data-driven solutions are optimizing pharma sales operationsSaloni Panse
Data-driven solutions are optimizing pharma sales operations by providing better customer insights. Pharmaceutical companies are embracing technologies like data analytics and sales automation infrastructure to streamline processes, eliminate errors, and deliver consistent growth amid industry pressures. These technologies provide centralized data repositories, boost sales effectiveness with more targeted outreach, and give companies a competitive edge over those not harnessing analytics. Prescriber360 aims to revolutionize pharma sales operations for companies through their cloud-based platform that generates insights from product and customer data to optimize operations.
Christopher Anderson SPHR CBS VP HR Latest Human ResourcesJerome Matthews
Latest Human Resources Trends in the Pharmaceutical Industry.
The pharmaceutical industry is undergoing an unprecedented transformation due to the changes in its environment.
Pharmaceutical companies need to leverage technology more strategically in their marketing and communications. Technology is changing how providers and patients interact and receive information. It allows access to more data and provides opportunities to improve patient engagement, adherence, and ROI measurement. Pharma companies must capitalize on technology now to engage customers and measure impact, before competitors do. Technology presents opportunities but also challenges pharmaceutical marketers to change their sales and marketing approaches.
Medical information: new ways, new strategiesMerqurio
The document discusses Salvatore Ruggiero's speech to the Faculty of Pharmacy at the University of Naples on December 10, 2009. Ruggiero is the CEO of Gruppo Merqurio, a pharmaceutical company that provides medical information services through a Contract Sales Organization (CSO) model. He outlines how the pharmaceutical industry is facing challenges like reduced blockbuster drug pipelines and increased regulations. Merqurio's CSO approach aims to optimize communication with physicians through strategies like e-detailing and phone representatives, while reducing costs for pharmaceutical companies. Ruggiero argues that CSOs can successfully meet the flexible needs of pharmaceutical firms by providing medical information and sales services through contracted representatives.
The consumer health market is undergoing rapid changes as it expands globally. Pharmaceutical companies have traditionally dominated this market but consumer packaged goods companies are increasingly entering it due to attractive growth. Both types of companies need to combine scientific expertise with a focus on consumers and marketing to succeed. Pharmaceutical companies currently have an advantage in regulating environments and product efficacy but need marketing expertise from consumer goods companies. The fight for talent in this evolving market is intense as companies need to attract professionals with diverse skills from both industries to drive innovation and adapt to changing trends.
Infographic: How to meet the new communication expectations?Kasper Roger Larsen
In partnership with Anthill agency we have produced this infographic with information on how to meet the new evolving expectations in digital communication for the life science industry.
eyeforpharma - White Paper - Goodbye sales and marketingAdam Hill
The document discusses how pharmaceutical companies are moving away from traditional sales and marketing models towards more integrated commercial models. Growing pressures in healthcare like the need to demonstrate drug value, specialty care, complex medicines, and patient-centricity require approaches beyond simple promotion. Companies are breaking down internal silos and converging sales, marketing, medical, and other functions into integrated teams that engage prescribers, payers, and patients through multichannel approaches to understand their needs. The future likely holds more fully integrated "customer engagement" departments in pharmaceutical companies.
Spotlight On... The Pharma Customer ExperienceCOUCH Health
In this edition, we’re shining our spotlight on the pharma customer experience. We discuss what customer experience really means in pharma, how it’s developing, who your audience is and why measuring emotion is vital.
Read online or download your free copy now! Then be sure to get in touch with us with any feedback or insights you have too – we’d love to continue the discussion…
Mera Medicare aims to change the landscape for pharmacists and customers by allowing online ordering and delivery of prescription drugs. To increase its pharmacist base, Mera Medicare will use a three-pronged approach - a sales team to explain the benefits, an operations team to assist with setting up home delivery logistics, and a technology team to help with integration. To expand its customer base, Mera Medicare will use social media marketing, develop a mobile app, promote through physical shops, and offer promotional discounts.
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)Eularis
With the ever-increasing pressure to ensure maximum return on investment, Sales Force Effectiveness is becoming a high priority area. A Sales Force represents the largest spend in sales and marketing and is second only to Research and Development within the whole of a company. Yet, similar to R & D, study after study shows that the returns gained from this spend are not particularly strong.
Research by Novartis shows, despite the fact that the top 40 Pharmaceutical companies in the US doubled their investment in Sales Force over the past 5 years, prescriptions only rose by 15% in the corresponding time period. Research by IBM concurred with this result and found that every dollar spent on Sales Force generates just $10.30 in sales. This represents a 22% drop in return since 1996.
Generally, there has been an industry-wide decrease in productivity per Sales Representative, down 24% since 1996. In addition, the Sales Representatives that are hired are low in age, output and skill. Reps face a highly competitive field, with recent figures showing a field of 90,000 Reps competing for 650,000 Physicians - only 125,000 of whom are top tier prospects. A rapidly expanding Sales Force with rapidly decreasing productivity results in an approximate 18% turnover each year.
Fortunately, the concept that ‘size sells’ is largely beginning to be abandoned across the Pharmaceutical Industry. Many Sales Managers are turning their attention to increasing the effectiveness of the Sales Force, rather than the size.
In this report, we examine Sales Force Effectiveness in the Pharmaceutical Industry. We analyze current metrics and their limitations, in focus and in measuring Sales Force Effectiveness, for the Pharmaceutical Industry. Then we discuss appropriate metrics to solve these problems, and demonstrate implementation methods and issues.
This Presentation help organization in development of his sales teams. As the most important and expensive resource of any organization is his people. So to make his people productive, one should work on their development and make them " Efficiently Effective People". In this presentation , the of importance of " Sales Force Effectiveness Department" in an organization has been established. Every organization want that his sales team should fulfill quantitative objectives of organization. This presentation is specially for pharmaceuticals.
The pharmaceutical industry faces an identity crisis as the competitive landscape changes rapidly. The document outlines four potential strategies for pharmaceutical companies: 1) Breakthrough science developers focus on developing new medicines through strong R&D. 2) Disease outcome enablers build expertise in specific therapeutic areas and support patients. 3) Commercial value optimizers leverage large global networks and efficient operations. 4) Disciplined portfolio managers operate diversified business units but face integration challenges. To succeed, companies must evaluate their current strategy and capabilities to ensure they can outperform competitors given new industry dynamics.
The CEMA South Africa 2016 summit will bring together senior pharmaceutical executives, government representatives, private health insurers, and other key decision makers. The goal is to promote collaboration across stakeholders and address barriers to ensuring patient access to essential medicines in South Africa. Over two days, the event will feature panels, case studies, and networking opportunities. Attendees will learn strategies for optimizing pricing and supply, integrating marketing and market access, and achieving real collaboration with payers to streamline market access. The speaker faculty includes leaders from major pharmaceutical companies, health insurers, and academic institutions.
Similar to Christopher Anderson SPHR CBS VP HR Hiring Trends (20)
The Rules Do Apply: Navigating HR ComplianceAggregage
https://www.humanresourcestoday.com/frs/26903483/the-rules-do-apply--navigating-hr-compliance
HR Compliance is like a giant game of whack-a-mole. Once you think your company is compliant with all policies and procedures documented and in place, there’s a new or amended law, regulation, or final rule that pops up landing you back at ‘start.’ There are shifts, interpretations, and balancing acts to understanding compliance changes. Keeping up is not easy and it’s very time consuming.
This is a particular pain point for small HR departments, or HR departments of 1, that lack compliance teams and in-house labor attorneys. So, what do you do?
The goal of this webinar is to make you smarter in knowing what you should be focused on and the questions you should be asking. It will also provide you with resources for making compliance more manageable.
Objectives:
• Understand the regulatory landscape, including labor laws at the local, state, and federal levels
• Best practices for developing, implementing, and maintaining effective compliance programs
• Resources and strategies for staying informed about changes to labor laws, regulations, and compliance requirements
1. HiringTrendsImpactingPharma& biotechindustries
Here are the hiringtrendsaffectingpharmaceuticals.
1. Lean SalesForceswithMore Emphasison e-Marketing
Pharmaceutical salesforcesare becomingleanerandare operatingunderdifferent structuresthan
theyusedto.More flexible,specializedregional salesteamsare gainingprominence.E-Marketingis
beingemphasizedbymanypharmaceutical companiesdue tothe ever-increasingdemandson
physicians'time andthe additionof formularymanagerstomanylargerhealthcare organizations
and hospitals.The resultisthatpharmaceutical recruitersare lookingforjobcandidateswith
flexibilityandtechnologyskills.
2. RepsWith BroaderProductKnowledge
Pharma salesrepswill have tounderstandandtalkaboutmore productsthan theyinthe past.The
ideaisthat these reps,withtheirbroaderproductknowledge,cantake a more instinctive,in-the-
momentapproachto a salessituation,offeringmore optionswhile still remainingwithinthe
boundariesof whatthey're allowedtodiscuss.(They're not,forexample,allowedtodiscussoff-label
usesof drugs withdoctors.)
3. A ShiftAwayfromPrimaryCare SalesReps
Pharma repswithcertainspecializedskillsare expectedtobe inhigherdemand.A repmayspecialize
incertaincancer drugs and have encyclopedicknowledge of how variousinsurersreimburse their
costs.A rep whocallsmostlyuponfamilymedicinepracticesmayneedtobe skilledinknowing
whichdrugsare reimbursedunderwhichinsurance planformularies.Thisisimportantinformation
for physiciansandtheirpatients.The pharmasalesrepwhomakessolelytraditional salescallsto
familypractitionersisbecominglesscommon.
4. Convergence BetweenTechGiantsandPharmaceuticals
The confluence betweentechnologyandpharmaceuticalsisnosurprise,butnow companieslike
Google are hintingat intentionsof engagingatthe consumerlevelbydevelopinghealthcare
productsfor consumers.Wearables,likethe Apple WatchandFitBit,are examplesof the tech-health
partnership.Expectmore convergence overthe nextyearortwo.Ultimately,thiscouldresultin
additional competitionforsome biotechandpharmaceuticalfirmsanditcouldmeanmore demand
for workerswithacombinationof techand pharmaskills.
5. More Emphasison Long-TermRelationshipBuilding
Ethicsregulationsinpharmaceuticalshave become tighterinrecentyears,sopracticeslike providing
"incentives"forphysiciansinordertogain theirattentionare nolongerstandard.Pharmarepswill
have to relyonthe old-fashionedskill of buildingstrong,long-lastingrelationshipswithclients.Some
of these relationshipswill be builtonhighly-specializedknowledgefromspecialistreps,butoverall,
the goal isfor pharmaceutical repstopositionthemselvesasprime educationalresourcesfor
doctors.
6. PartnershipsBetweenBigPharmaandStartups
2. Big pharmaceutical companiesandbiotechstart-upsare expectedtobecome partnersmore oftenin
comingyears.It usuallybeginswhenabigpharmacompany recognizesastart-upwithapromising
productand developsapartnershipbaseduponthatproduct.Insome cases,itwill involve
pharmaceutical companiesinvestingseedmoneyintostartups.Itmaywell move toa scenario
where pharmaceutical companiesheavilyinfluence how startupsspendthatmoneyandwill typically
endup withan acquisition.The endresultisexpectedtobe increasedhiringin2016.
Source : Hire perfectblog
Recommendedby:
CHRISTOPHERT. ANDERSON, SPHR,CBS
Vice President,HumanResources
Mölnlycke HealthCare,Atlanta,GA
email:ctanderson209@sbcglobal.net
https://www.linkedin.com/in/chrisandersonsphr
Mölnlycke HealthCare,AbbottLaboratories,HospiraInc.,Hill-Rom,The Ertl Company
Pharma, Pharmaceuticals,Biopharm, Biopharmaceuticals,Medical Devices,Biotech,Biotechnology
http://www.zoominfo.com/z/ChrisAnderson
http://www.yatedo.com/p/CHRISTOPHER+ANDERSON/normal/e23ed9da3ff1b552ba6fcd85dff79f0c
https://www.intelius.com/Find-Phone-Address/Dubuque-IA/Christopher-Anderson.html
https://www.visualcv.com/christopher-t-anderson
https://connect.data.com/contact/view/t3nVaN-mtGLcWTv2axRPyg/christopher-t-anderson
about.me/c.anderson
https://docs.google.com/document/d/1AR4wGYccj9mU4c_LM0HWM8mxGfbszz0v1FCHAd-
J0PA/edit?usp=sharing
https://drive.google.com/file/d/0B9UWO5DpC2g6N3E0RktyOXk1bkk/view?usp=sharing
https://chrisandersonweb.wordpress.com/2016/07/08/christopher-t-anderson-sphr-cbs/
http://www.slideshare.net/JeromeMatthews1/christopher-anderson-vice-president-human-
resources-63899602
https://www.scribd.com/document/317951809/Christopher-Anderson-Vice-President-Human-
Resources
https://issuu.com/christophertanderson/docs/christopher_anderson_vice_president